login
login

Europe Daily Bulletin No. 8934

23 April 2005
Contents Publication in full By article 42 / 47
ECONOMIC INTERPENETRATION / (eu) healthcare

The British pharmaceuticals group SHIRE PHARMACEUTICALS (turnover of 1.363 billion dollars in 2004) has acquired the American company TRANSKARYOTIC THERAPIES for 1.6 billion dollars. The operation, which was finalised in the summer, will be paid for in cash at 37 dollars a share.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
TIMETABLE
ECONOMIC INTERPENETRATION
SUPPLEMENT